Overview
ISS offers 20 years of experience matching research sites to protocol requirements. Sponsors and CROs save time and staff
resources by selecting from an expanded network of investigators, pre-qualified to meet individual study needs. Our data-driven site evaluation process ensures the most qualified sites are rapidly matched to your studies, at no charge.
Research Network
ISS provides access to phase I-IV sites employing experienced research personnel and support staff. Our multinational network offers:
- 250 sites in North America, experienced in all therapeutic areas
- 20 Phase I Units with 35 prior trials conducted, on average
Qualifications and Expertise
Our sites offer a diverse range of capabilities and experience in investigational drug and medical device trials. ICH/GCP-trained investigators offer board certification in virtually every medical specialty, averaging 86 trials conducted and 14 years in research. Trials are further
supported with an average of three coordinators per site, many with ACRP certifications and nursing degrees.
Benefits of Working with ISS
To reduce the time and costs associated with site selection, ISS supports sponsors and CROs with:
- Access to 1600 investigators in the US and Canada
- Data-driven pre-qualification to identify sites matching study needs
- Trained and experienced full-time staff
- Rapid site submissions to avoid costly delays in start-up
- No obligation as the sponsor/CRO makes the final selection decision
- No fee to work with ISS for your site selection needs
|
